PFE

Take the Risk for Reward With Pfizer Options

Given the recent breakout and the solid fundamentals, I like the ratio of risk to reward of both the Pfizer (PFE) February 33 and March 33 call options. More 

Why Investors Can Feel Good About China’s Generic Drugs

Domestic companies stand to gain from growth in what’s now $45 billion market for generics drugs in China. More 

Biggest Movers in Healthcare Stocks Now – NVO AMGN ESRX BDX

Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.2%. More 

Biggest Movers in Healthcare Stocks Now – ACHN IRWD MACK ISIS

Healthcare stocks rose 0.6% on Wall Street on Wednesday. More 

Top 10 Dow Dividend Stocks for December

If you're looking for a place to start your hunt for yield, you could do a lot worse than some of the Dow's highest-yielding dividend stocks. More 

3 Best Dividend Stocks to Buy for Retirement

These three established, cash-rich dividend stocks offer significant income for those looking for stability in retirement. More 

Pfizer’s ‘Head-and-Shoulders’ Top Is a Bad Sign

Pfizer has reached the end of its distribution period, and PFE stock has broken down in a reversal to a new downtrend. More